Search research articles
Contact Us
Filters
Showing results (261-270 of 295) with videos related to
Page
of 30
Sort By:
Zhonghua Yi Xue Za Zhi
|
December 16, 2025
[Application effects of programmed cell death protein 1 antibody-internalizing Arg-Gly-Asp peptide conjugate combined with adoptive T cell therapy in cold tumors]
Y F Pan, S J Ren, W Q Liu, et al.
Leukemia
|
October 8, 2015
Efficacy and safety of extended dosing schedules of CC-486 (oral azacitidine) in patients with lower-risk myelodysplastic syndromes
G Garcia-Manero, S D Gore, S Kambhampati, et al.
The Journal of Clinical Investigation
|
February 2, 1999
Protein 4.1R-deficient mice are viable but have erythroid membrane skeleton abnormalities
Z T Shi, V Afzal, B Coller, et al.
Public Health
|
April 27, 2010
Establishment and evaluation of a model of a community health service in an underdeveloped area of China
H Hu, W Liang, M Liu, et al.
Antimicrobial Agents and Chemotherapy
|
March 25, 2009
Preclinical characterization of PF-00868554, a potent nonnucleoside inhibitor of the hepatitis C virus RNA-dependent RNA polymerase
Stephanie T Shi, Koleen J Herlihy, Joanne P Graham, et al.
Zhonghua Nei Ke Za Zhi
|
March 27, 2020
[Clinical features and prognostic factors of primary gastric neuroendocrine neoplasms]
Y J Xiong, X Y Liu, C E Cheng, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
October 28, 2008
Oil-filled polymer microcapsules for ultrasound-mediated delivery of lipophilic drugs
Klazina Kooiman, Marcel R Böhmer, Marcia Emmer, et al.
Journal of Dental Research
|
March 21, 2023
Ligature-Induced Periodontitis Drives Colorectal Cancer: An Experimental Model in Mice
Y T Shi, J M He, Z A Tong, et al.
Antimicrobial Agents and Chemotherapy
|
December 12, 2007
In vitro resistance study of AG-021541, a novel nonnucleoside inhibitor of the hepatitis C virus RNA-dependent RNA polymerase
Stephanie T Shi, Koleen J Herlihy, Joanne P Graham, et al.
ESMO Open
|
February 20, 2024
Efficacy and safety of intrathecal pemetrexed for TKI-failed leptomeningeal metastases from EGFR+ NSCLC: an expanded, single-arm, phase II clinical trial
C Fan, Z Jiang, C Teng, et al.
Page
of 30
Search research articles
Search
Showing results (261-270 of 295) with videos related to
Sort By:
Page
of 30
Zhonghua Yi Xue Za Zhi
|
December 16, 2025
[Application effects of programmed cell death protein 1 antibody-internalizing Arg-Gly-Asp peptide conjugate combined with adoptive T cell therapy in cold tumors]
Y F Pan, S J Ren, W Q Liu, et al.
Leukemia
|
October 8, 2015
Efficacy and safety of extended dosing schedules of CC-486 (oral azacitidine) in patients with lower-risk myelodysplastic syndromes
G Garcia-Manero, S D Gore, S Kambhampati, et al.
The Journal of Clinical Investigation
|
February 2, 1999
Protein 4.1R-deficient mice are viable but have erythroid membrane skeleton abnormalities
Z T Shi, V Afzal, B Coller, et al.
Public Health
|
April 27, 2010
Establishment and evaluation of a model of a community health service in an underdeveloped area of China
H Hu, W Liang, M Liu, et al.
Antimicrobial Agents and Chemotherapy
|
March 25, 2009
Preclinical characterization of PF-00868554, a potent nonnucleoside inhibitor of the hepatitis C virus RNA-dependent RNA polymerase
Stephanie T Shi, Koleen J Herlihy, Joanne P Graham, et al.
Zhonghua Nei Ke Za Zhi
|
March 27, 2020
[Clinical features and prognostic factors of primary gastric neuroendocrine neoplasms]
Y J Xiong, X Y Liu, C E Cheng, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
October 28, 2008
Oil-filled polymer microcapsules for ultrasound-mediated delivery of lipophilic drugs
Klazina Kooiman, Marcel R Böhmer, Marcia Emmer, et al.
Journal of Dental Research
|
March 21, 2023
Ligature-Induced Periodontitis Drives Colorectal Cancer: An Experimental Model in Mice
Y T Shi, J M He, Z A Tong, et al.
Antimicrobial Agents and Chemotherapy
|
December 12, 2007
In vitro resistance study of AG-021541, a novel nonnucleoside inhibitor of the hepatitis C virus RNA-dependent RNA polymerase
Stephanie T Shi, Koleen J Herlihy, Joanne P Graham, et al.
ESMO Open
|
February 20, 2024
Efficacy and safety of intrathecal pemetrexed for TKI-failed leptomeningeal metastases from EGFR+ NSCLC: an expanded, single-arm, phase II clinical trial
C Fan, Z Jiang, C Teng, et al.
Page
of 30